Global Orthopedic Biomaterials Market 2018-2022
About this market
Increasing focus on customizing material properties to drive growth in the market. There is a growing focus on customizing the material properties of composite and bioabsorbable materials with fillers like bioactive ceramics for nonpermanent devices. PEEK biomaterials, which are variations of PAEK biomaterials, have been used in spinal implants, and as bearing materials for hip and knee replacement, and hip resurfacing. Technavio’ s analysts have predicted that the orthopedic biomaterials market will register a CAGR of close to 7% by 2022.
Increasing prevalence of musculoskeletal diseases and disorders
The increasing burden of musculoskeletal disorders subsequently increases the demand for orthopedic biomaterials used to repair such conditions.
High cost of orthopedic bioimplants and surgeries
The high cost of orthopedic bioimplants and surgeries is restricting the widespread adoption of orthopedic biomaterials in several developed as well as developing countries.
For the detailed list of factors that will drive and challenge the growth of the orthopedic biomaterials market during the 2018-2022, view our report.
The market appears to be fragmented and with the presence of several companies including Medtronic and Smith & Nephew the competitive environment is quite intense. Factors such as the increasing prevalence of musculoskeletal diseases and disorders and the increasing focus on customizing material properties, will provide considerable growth opportunities to orthopedic biomaterials manufactures. B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet are some of the major companies covered in this report.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook